BR100 Increased By (0.01%)
BR30 Decreased By (-0.27%)
KSE100 Increased By (0.05%)
KSE30 Increased By (0.03%)
AGHA 6.71 Increased By ▲ 0.03 (0.45%)
BECO 4.37 No Change ▼ 0.00 (0%)
BML 56.95 Decreased By ▼ -0.37 (-0.65%)
BOP 30.36 Increased By ▲ 0.01 (0.03%)
CNERGY 13.11 Decreased By ▼ -0.01 (-0.08%)
CSIL 5.34 Decreased By ▼ -0.07 (-1.29%)
FCCL 52.76 Decreased By ▼ -0.03 (-0.06%)
FFL 14.61 Decreased By ▼ -0.11 (-0.75%)
FNEL 1.13 Increased By ▲ 0.01 (0.89%)
KEL 6.17 Increased By ▲ 0.08 (1.31%)
KOSM 6.14 Increased By ▲ 0.41 (7.16%)
LOTCHEM 26.50 Increased By ▲ 0.04 (0.15%)
MLCF 93.10 Decreased By ▼ -0.06 (-0.06%)
NBP 164.99 Increased By ▲ 0.33 (0.2%)
NCPL 55.60 Decreased By ▼ -0.06 (-0.11%)
NPL 60.85 Decreased By ▼ -0.31 (-0.51%)
OGDC 315.52 Decreased By ▼ -1.21 (-0.38%)
PACE 9.99 Increased By ▲ 0.12 (1.22%)
PAEL 35.63 No Change ▼ 0.00 (0%)
PIBTL 14.85 Increased By ▲ 0.17 (1.16%)
PPL 224.50 Decreased By ▼ -2.41 (-1.06%)
PRL 93.00 Decreased By ▼ -0.02 (-0.02%)
PTC 60.20 Decreased By ▼ -0.06 (-0.1%)
SSGC 23.85 Increased By ▲ 0.04 (0.17%)
TBL 8.75 No Change ▼ 0.00 (0%)
TELE 7.81 Increased By ▲ 0.01 (0.13%)
TPL 22.34 Decreased By ▼ -0.01 (-0.04%)
TPLP 12.80 Decreased By ▼ -0.17 (-1.31%)
TREET 22.15 Decreased By ▼ -0.01 (-0.05%)
TRG 56.75 Increased By ▲ 0.19 (0.34%)

KARACHI: Economic and financial analyst Ateeq ur Rahman has said shortage of medicines or their rising cost is like adding salt to injury, thus affecting the health sector as a whole. People or patients, those who are used to regular dosage of medicines for their struggle of life to survive, need an easy access to medicines.

In these inflationary conditions if the essential medicines get expensive by the day or become impossible to reach, whatever may be the reason, is not a good situation.

Less storage capacities, unavailability of raw material due to restrictions on opening of letter of credit or devaluation of currency, etc are big hurdles in the production of pharmaceutical goods, thus creating paucity and raising the cost of medicines.

This is unbearable by majority of population, most of them are either poor or deprived or middle class to afford such increase in prices.

The government and authorities should urgently look into this severe problem and address the hindrance and production at the earliest, eventually improving the supply line and reducing the cost of medicines.

Copyright Business Recorder, 2022

Comments

Comments are closed for this article.